Merck KGaA Revives Sale of Allergy Therapy Business

(Bloomberg) -- Merck KGaA is reviving plans for a potential sale of its allergy business, people with knowledge of the matter said.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.